Zobrazeno 1 - 10
of 214
pro vyhledávání: '"So Yeon Nam"'
Autor:
Dong-Yeon Nam, Je-Keun Rhee
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-15 (2024)
Abstract Predicting clinical responses to tumor immunotherapy is essential to reduce side effects and the potential for sustained clinical responses. Nevertheless, preselecting patients who are likely to respond to such treatments remains highly chal
Externí odkaz:
https://doaj.org/article/464a18c23f9a40ce85fc5c354cee7463
Autor:
Namgi Park, Jiyeon Bae, Soo Yeon Nam, Ji Yun Bae, Kang-Il Jun, Jeong-Han Kim, Chung-Jong Kim, Kyunghee Kim, Sun Ah Kim, Hee Jung Choi, Sandy Jeong Rhie
Publikováno v:
Pharmaceuticals, Vol 17, Iss 7, p 854 (2024)
In South Korea, because of manpower and budgetary limitations, antimicrobial stewardship programs have relied on preauthorization. This study analyzed the impact of a prospective audit and feedback (PAF) program targeting inpatients undergoing interm
Externí odkaz:
https://doaj.org/article/7b8f3762050942f9b582771db08daef7
Autor:
Sungpil Han, Hee Youn Choi, Yo Han Kim, SeungChan Choi, Seokuee Kim, Ji Yeon Nam, Bongtae Kim, Geun Seog Song, Hyeong-Seok Lim, Kyun-Seop Bae
Publikováno v:
Gut and Liver, Vol 17, Iss 1, Pp 92-99 (2023)
Background/Aims: Tegoprazan, a novel potassium-competitive acid blocker, is expected to overcome the limitations of proton pump inhibitors and effectively control nocturnal acid breakthrough. To evaluate the pharmacodynamics of tegoprazan versus dexl
Externí odkaz:
https://doaj.org/article/031c5badeb3d4a6fa541965019b9a495
Autor:
Minsang Kim, Yeongmi Cheon, Dongmin Shin, Jieun Choi, Josefine Eilsø Nielsen, Myeong Seon Jeong, Ho Yeon Nam, Sung‐Hak Kim, Reidar Lund, Håvard Jenssen, Annelise E. Barron, Seongsoo Lee, Jiwon Seo
Publikováno v:
Advanced Science, Vol 10, Iss 24, Pp n/a-n/a (2023)
Abstract Antimicrobial peptides (AMPs) are promising therapeutics in the fight against multidrug‐resistant bacteria. As a mimic of AMPs, peptoids with N‐substituted glycine backbone have been utilized for antimicrobials with resistance against pr
Externí odkaz:
https://doaj.org/article/b83c343184e24617b1e454cf97703cb1
Autor:
Koteswara Rao Kamma, Joungmo Cho, Hyo Jun Won, So-Yeon Nam, Ngan Hong Le, Je Hyeong Jung, Kee-In Lee
Publikováno v:
Molecules, Vol 29, Iss 2, p 513 (2024)
During the synthetic studies toward 5,6,7,3′,4′-monomethoxytetrahydroxyflavones, a concise pedalitin synthesis procedure was achieved. As previously reported, 6-hydroxy-2,3,4-trimethoxyacetophenone was prepared by Friedel–Crafts acylation of 1,
Externí odkaz:
https://doaj.org/article/e245aac155184e0191281f779159dbe5
Autor:
Hyun Jeong Kim, Yong Hwan Kwon, Seong Woo Jeon, Su Yeon Nam, Hyun Suk Lee, Joon Seop Lee, Chang Min Cho, Ki Tae Kwon, Ji Yeon Ham, Changho Kim
Publikováno v:
The Korean Journal of Helicobacter and Upper Gastrointestinal Research, Vol 20, Iss 3, Pp 248-250 (2020)
Externí odkaz:
https://doaj.org/article/2ff25f607f504ea392b0e074cebad39f
Autor:
Dong-Yeon Nam, Je-Keun Rhee
Publikováno v:
Biology, Vol 11, Iss 5, p 787 (2022)
Tumor purity refers to the proportion of tumor cells in tumor tissue samples. This value plays an important role in understanding the mechanisms of the tumor microenvironment. Although various attempts have been made to predict tumor purity, attempts
Externí odkaz:
https://doaj.org/article/96ef87bcff1b43a5927d6ed6ff1433b1
Autor:
Seung-Yeon Nam, Seok-Hyeon Choi
Publikováno v:
Journal of Public Society. 13:5-41
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6af4b9bdb109b6cb677444a83f5b4458
https://doi.org/10.21286/jps.2023.02.13.1.5
https://doi.org/10.21286/jps.2023.02.13.1.5
Autor:
Ju-Young Lee, Jin Han Nam, Youngpyo Nam, Hye Yeon Nam, Gwangho Yoon, Eunhwa Ko, Sang-Bum Kim, Mahealani R Bautista, Christina C Capule, Takaoki Koyanagi, Geoffray Leriche, Hwan Geun Choi, Jerry Yang, Jeongyeon Kim, Hyang-Sook Hoe
Publikováno v:
Journal of Neuroinflammation, Vol 15, Iss 1, Pp 1-23 (2018)
Abstract Background Neuroinflammation is associated with neurodegenerative diseases, including Alzheimer’s disease (AD). Thus, modulating the neuroinflammatory response represents a potential therapeutic strategy for treating neurodegenerative dise
Externí odkaz:
https://doaj.org/article/dfda851a974a40adb2093666dc7b1d5f
Autor:
Hye Yeon Nam, Jin Han Nam, Gwangho Yoon, Ju-Young Lee, Youngpyo Nam, Hye-Jin Kang, Hyun-Ji Cho, Jeongyeon Kim, Hyang-Sook Hoe
Publikováno v:
Journal of Neuroinflammation, Vol 15, Iss 1, Pp 1-22 (2018)
Abstract Background The FDA-approved small-molecule drug ibrutinib is an effective targeted therapy for patients with chronic lymphocytic leukemia (CLL). Ibrutinib inhibits Bruton’s tyrosine kinase (BTK), a kinase involved in B cell receptor signal
Externí odkaz:
https://doaj.org/article/d1acb3d4dfb24e0fb68f13dcd83b7090